Specificity of cyclic AMP potentiation of glucose-stimulated insulin release.
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002087:Butyrates; D000242:Cyclic AMP / Q000494:pharmacology*; D006152:Cyclic GMP / Q000494:pharmacology; D003597:Cytosine Nucleotides / Q000494:pharmacology; D004357:Drug Synergism; D005260:Female; D005947:Glucose / Q000494:pharmacology*; D006160:Guanosine Triphosphate / Q000494:pharmacology; D006943:Hyperglycemia / Q000378:metabolism; D066298:In Vitro Techniques; D007292:Inosine Nucleotides / Q000494:pharmacology; D007328:Insulin / Q000378:metabolism*; D007330:Insulin Antibodies; D000078790:Insulin Secretion; D007457:Iodine Radioisotopes; D007515:Islets of Langerhans / Q000378:metabolism*; D051379:Mice; D009712:Nucleotides, Cyclic / Q000494:pharmacology; D009765:Obesity / Q000378:metabolism; D014500:Uracil Nucleotides / Q000494:pharmacology
D002087:Butyrates; D003597:Cytosine Nucleotides; D007292:Inosine Nucleotides; D007328:Insulin; D007330:Insulin Antibodies; D007457:Iodine Radioisotopes; D009712:Nucleotides, Cyclic; D014500:Uracil Nucleotides; D003994:Bucladesine; D006160:Guanosine Triphosphate; D000255:Adenosine Triphosphate; D000242:Cyclic AMP; D006152:Cyclic GMP; D005947:Glucose